의료용 로봇 시스템 시장 보고서 : 제품별, 도입 형태별, 최종사용자별, 지역별(2026-2034년)

The global medical robotic systems market size reached USD 26.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 97.8 Billion by 2034, exhibiting a growth rate (CAGR) of 15.23% during 2026-2034. Technological innovations, the rising demand for minimally invasive surgeries, the surging prevalence of chronic diseases, and investment in healthcare are primarily driving the market growth.

MEDICAL ROBOTIC SYSTEMS MARKET ANALYSIS:

• Major Market Drivers: The increasing demand for minimally invasive surgeries (MIS), owing to the escalating preference for smaller incisions, fewer cuts, decreased scarring, reduced pain, improved safety, and faster recovery periods that are associated with MIS across the surgical domain, is propelling the market growth.
• Key Market Trends: The rising geriatric population and the continual technological advancements in novel surgical modalities are bolstering the market growth across the globe. Moreover, the augmenting need for automation in the healthcare industry, a considerable rise in the cases of trauma injuries, and the rapidly expanding medical tourism sector are also acting as significant growth-inducing factors.
• Competitive Landscape: Some of the prominent companies in the market include Accuray Incorporated, Globus Medical, Intuitive Surgical Operations, Inc, Johnson & Johnson, Medtronic plc, Omnicell, Siemens Healthineers AG, Smith+Nephew, Stereotaxis, Inc., Stryker Corporation, Titan Medical Inc., and Zimmer Biomet, among many others.
• Geographical Trends: North America exhibits a clear dominance in the market, on account of the novel advancements in robotic technologies such as surgical robots, rehabilitation robots , and robotic-assisted therapy systems. These advancements enhance precision, accuracy, and effectiveness in medical procedures, thereby driving adoption.
• Challenges and Opportunities: High initial costs and safety concerns associated with robotic systems are hampering the market growth. However, the rising usage of artificial intelligence (AI), machine learning, and haptics to enhance the capabilities and precision of medical robotic systems is expected to fuel the market over the forecasted period.

MEDICAL ROBOTIC SYSTEMS MARKET TRENDS:

Increasing Demand for Minimally Invasive Surgeries

The increasing adoption of robotic systems for minimally invasive surgeries drives the market growth. Patients prefer minimally invasive surgery due to the lower risk of complications and reduced hospitalization periods. For instance, according to a cross-sectional study of 305 VV-afflicted patients at Zhejiang Rongjun Hospital between January 2022 and June 2023 evaluated the treatment preferences of the patients. Out of the 96 patients who selected an option of treatment, nearly 24.0% went with traditional surgery, and 76.0% went with MIT. Moreover, manufacturers are expanding their product offerings and upgrading existing systems to meet the demand for advanced surgical capabilities and technological innovations. For instance, in April 2024, Manipal Hospital, Kharadi, launched advanced robotic knee replacement surgery, which promised more precision, faster recovery times, and less discomfort than traditional surgeries. This provides advantages, such as sub-millimeter accuracy during implant surgery, a lower risk of infection, and the prospect of speedier recovery and release within 24 hours. This breakthrough technique allows patients to have minimally invasive surgery with reduced recovery periods, higher precision, and a better quality of life. These factors are further driving the medical robotic systems market growth.

Adoption of Surgical Robots

Surgical robots offer superior precision, skill, and accuracy compared to traditional surgical techniques. They enable surgeons to perform complex procedures. For instance, according to an article published by Mayo Clinic, during surgery, robotic technology can help surgeons be more precise, flexible, and in control. When compared to conventional surgical techniques, robotic technology also improves the visibility of the operating site. Surgeons can carry out intricate and delicate treatments with robotic surgery that would be challenging or impossible to accomplish with other techniques. Besides this, favorable regulatory approvals and reimbursement policies for robotic-assisted surgeries support market growth. Healthcare regulatory bodies recognize the clinical benefits of robotic systems and encourage their adoption through streamlined approval processes. For example, in March 2024, Intuitive received U.S. Food and Drug Administration (FDA) 510(k) certification for their fifth-generation multiport robotic system, called da Vinci 5. With more than 150 improvements, it boasts the first force-sensing technology, a next-generation 3D display and image processing, and increased precision. With customizable posture and the option to make changes while using the console, the da Vinci 5 system's revamped console provides surgeons with increased comfort. These factors are further escalating the growth of the global medical robotic systems market.

Technological Advancements

Modern medical robotic systems leverage advanced imaging technologies, such as high-definition cameras, 3D visualization, and real-time image processing. These technologies provide surgeons with detailed, magnified views of the surgical site, enabling precise manipulation of tissues and organs. For instance, in June 2024, Endiatx, a medical technology company, unveiled its robotic pill to the market. The PillBot is an ingestible robotic capsule that has cameras, sensors, and wireless communication capabilities, allowing clinicians to investigate the gastrointestinal tract with unprecedented accuracy and control. Enhanced accuracy reduces the risk of human error and improves surgical outcomes, particularly in complex procedures. Besides this, AI and machine learning algorithms are increasingly integrated into medical robotic systems to enhance decision-making capabilities and automate complex tasks. AI-powered systems can analyze vast amounts of data in real-time, predict surgical outcomes, and assist surgeons in planning and executing procedures more effectively. For example, in October 2023, Body Vision Medical launched a new software update for its LungVision(TM) navigation and real-time imaging platform. The update includes the latest AI Tomography imaging algorithm, a streamlined workflow for robotic-assisted bronchoscopy (RAB), reduced radiation exposure for medical staff and patients during lung nodule biopsy procedures, etc. These factors are further driving the medical robotic systems market size.

GLOBAL MEDICAL ROBOTIC SYSTEMS INDUSTRY SEGMENTATION:

Breakup by Product:

• Surgical Robots
  • Orthopedic Surgical Robots
  • Neurosurgical Robotic Systems
  • Laparoscopy Robotic Systems
  • Steerable Robotic Catheters
• Rehabilitation Robots
  • Assistive Robots
  • Prosthetics
  • Orthotics
  • Therapeutic Robots
  • Exoskeleton Robotic Systems
• Noninvasive Radiosurgery Robots
  • TrueBeam STx Radiosurgery System
  • CyberKnife Robotic Radiosurgery System
  • Gamma Knife Perfexion Radiosurgery System
• Hospital and Pharmacy Robots
  • Telemedicine Robots
  • I.V. Robots
  • Cart Transportation Robots
• Emergency Response Robotic Systems

Surgical robots represented the largest segment

According to the medical robotic systems market overview, surgical robots enable minimally invasive procedures with smaller incisions, reduced trauma to surrounding tissues, and faster recovery times compared to traditional open surgeries. Patients benefit from less pain, shorter hospital stays, and quicker return to normal activities, driving demand for robotic-assisted surgeries. They offer enhanced precision and accuracy in surgical maneuvers, leveraging advanced imaging, robotic arm talent, and real-time feedback mechanisms. Surgeons can perform complex procedures with greater control and precision, minimizing risks and improving surgical outcomes. For instance, in June 2024, SS Innovations, the developer of India's first indigenous surgical robotic system, launched SSI Mantra 3, a robotic system that enables affordable access to the next generation of surgical innovation.

Breakup by Deployment Mode:

• On-premises
• Cloud-based

On-premises medical robotic systems are hosted and managed within the healthcare facility's infrastructure, typically within a dedicated surgical suite or operating room. Moreover, healthcare providers have full control over the system's hardware, software, and data management, which is positively influencing the medical robotic systems market prediction. This allows for stringent security measures and compliance with healthcare data privacy regulations. At the same time, cloud-based medical robotic systems leverage cloud computing infrastructure to store data and perform computational tasks remotely. This enables access to robotic capabilities from multiple locations, including different healthcare facilities and remote surgical centers.

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Rehabilitation Centers
• Others

Hospitals are major users of medical robotic systems, particularly for complex surgeries that require precision and advanced capabilities. Robotic systems enable surgeons to perform intricate procedures with enhanced precision, reducing the risk of complications and improving patient outcomes. While ASCs increasingly adopt medical robotic systems for performing minimally invasive surgeries (MIS), such as laparoscopic procedures, hernia repairs, and outpatient orthopedic surgeries. Robotic-assisted techniques allow ASCs to offer advanced surgical options with quicker recovery times and reduced post-operative pain. Besides this, in rehabilitation centers, medical robotics are used for neurorehabilitation therapies and assistive technologies. Robotic exoskeletons, prosthetics, and rehabilitation robots help patients regain mobility, improve muscle strength, and facilitate recovery from neurological conditions and musculoskeletal injuries.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America accounts for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

According to the medical robotic systems market statistics, continuous innovation in robotic technology, including AI integration, advanced imaging capabilities, and enhanced surgical navigation systems, has expanded the applications and precision of medical robotic systems in the region. These advancements improve surgical outcomes and patient safety, driving adoption across various specialties. Moreover, there is an increasing preference for minimally invasive procedures due to reduced recovery times, shorter hospital stays, and improved patient outcomes. Medical robotic systems enable surgeons to perform complex surgeries through smaller incisions with greater precision, enhancing the appeal of robotic-assisted procedures. For instance, in September 2023, U.S. Medical Innovations (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) launched the new Canady Robotic AI Surgical System.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

• Accuray Incorporated
• Globus Medical
• Intuitive Surgical Operations, Inc
• Johnson & Johnson
• Medtronic plc
• Omnicell
• Siemens Healthineers AG
• Smith+Nephew
• Stereotaxis, Inc.
• Stryker Corporation
• Titan Medical Inc.
• Zimmer Biomet

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global medical robotic systems market in 2025?

2. What is the expected growth rate of the global medical robotic systems market during 2026-2034?

3. What are the key factors driving the global medical robotic systems market?

4. What has been the impact of COVID-19 on the global medical robotic systems market?

5. What is the breakup of the global medical robotic systems market based on the product?

6. What are the key regions in the global medical robotic systems market?

7. Who are the key players/companies in the global medical robotic systems market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Robotic Systems Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Surgical Robots
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Orthopedic Surgical Robots
    • 6.1.2.2 Neurosurgical Robotic Systems
    • 6.1.2.3 Laparoscopy Robotic Systems
    • 6.1.2.4 Steerable Robotic Catheters
  • 6.1.3 Market Forecast
• 6.2 Rehabilitation Robots
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Assistive Robots
    • 6.2.2.2 Prosthetics
    • 6.2.2.3 Orthotics
    • 6.2.2.4 Therapeutic Robots
    • 6.2.2.5 Exoskeleton Robotic Systems
  • 6.2.3 Market Forecast
• 6.3 Noninvasive Radiosurgery Robots
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.3.2.1 TrueBeam STx Radiosurgery System
    • 6.3.2.2 CyberKnife Robotic Radiosurgery System
    • 6.3.2.3 Gamma Knife Perfexion Radiosurgery System
  • 6.3.3 Market Forecast
• 6.4 Hospital and Pharmacy Robots
  • 6.4.1 Market Trends
  • 6.4.2 Key Segments
    • 6.4.2.1 Telemedicine Robots
    • 6.4.2.2 I.V. Robots
    • 6.4.2.3 Cart Transportation Robots
  • 6.4.3 Market Forecast
• 6.5 Emergency Response Robotic Systems
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Deployment Mode

• 7.1 On-premises
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Cloud-based
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Rehabilitation Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Accuray Incorporated
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Globus Medical
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Intuitive Surgical Operations, Inc
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Johnson & Johnson
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Medtronic plc
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Omnicell
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Siemens Healthineers AG
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Smith+Nephew
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Stereotaxis, Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Stryker Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Titan Medical Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Zimmer Biomet
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis